299
Views
12
CrossRef citations to date
0
Altmetric
Review

Psychometric Properties of Cognitive Assessment in Amyotrophic Lateral Sclerosis: A Systematic Review

, ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon
Pages 181-194 | Published online: 22 Sep 2020

References

  • Strong M, Abrahams S, Goldstein L, et al. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:153–174.
  • Olney R, Murphy J, Forwhew D, et al. The effects of executive and behavioral dysfunction on the course of ALS. Neurology. 2005;65:1774–1777. doi:10.1212/01.wnl.0000188759.87240.8b
  • Pagnini F, Rossi G, Lunetta C, et al. Burden, depression, and anxiety in caregivers of people with amyotrophic lateral sclerosis. Psychol Health Med. 2010;15(6):685–693. doi:10.1080/13548506.2010.507773
  • Khin E, Minor D, Holloway A, Pelleg A. Decisional capacity in amyotrophic lateral sclerosis. J Am Acad Psychiatry Law. 2015;43:210–217.
  • Abrahams S, Newton J, Niven E, Foley G, Bak T. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(12):9–14. doi:10.3109/21678421.2013.805784
  • Bock M, Duong Y-N, Kim A, Allen I, Murphy J, Lomen-Hoerth C. Cognitive-behavioral changes in amyotrophic lateral sclerosis: screening prevalence and impact on patients and caregivers. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(56):366–373. doi:10.3109/21678421.2016.1165257
  • Beeldman E, Raaphorst J, Twennaar M, deVisser M, Schmand B, de Haan R. The cognitive profile of ALS: a systematic review and meta-analysis update. J Neurol Neurosurg Psychiatry. 2015;87(6):611–619. doi:10.1136/jnnp-2015-310734
  • Woolley S, Katz J. Cognitive and behavioral impairment in amyotrophic lateral sclerosis. Phys Med Rehabil Clin N Am. 2008;19(3):607–617. doi:10.1016/j.pmr.2008.04.002
  • Crockford CJ, Newton J, Lonergan K, et al. ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology. 2018;91.
  • Raaphorst J, de Visser M, Linssen WH, De Haan R, Schmand B. The cognitive profile of amyotrophic lateral sclerosis: a meta-analysis. Amyotrophic Lateral Sclerosis. 2010;11(12):27–37. doi:10.3109/17482960802645008
  • Woolley SC. Utility of the amyotrophic lateral sclerosis cognitive behavioral screen (ALS CBS™). Neurodegen Dis Manage. 2011;1(6):473–479. doi:10.2217/nmt.11.63
  • Liberati A, Altman D, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:10. doi:10.1016/j.jclinepi.2008.05.006
  • Taule T, Søvik M, Lein R, Wehling E, Aßmus J, Rekand T Cognitive assessment tools used in ALS-specific health-care: a systematic review of their psychometric properties. 2017; Available from: http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42017055603. Accessed August 15, 2020.
  • Brooks B, Miller R, Swash M, Munsat M. World federation of neurology research group on motor neuron diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293–299. doi:10.1080/146608200300079536
  • de Carvalho M, Dengler R, Eisen A, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119(3):497–503. doi:10.1016/j.clinph.2007.09.143
  • Brooks B. El escorial world federation of neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on motor neuron diseases/amyotrophic lateral sclerosis of the World federation of neurology research group on neuromuscular diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors. J Neurol Sci. 1994;124:96–107. doi:10.1016/0022-510x(94)90191-0
  • Clinical queries using research methodology filters. PubMed help [Internet] - Clinical queries using research methodology filters; 2005. Available from: https://www.ncbi.nlm.nih.gov/books/NBK3827/table/pubmedhelp.T.clinical_queries_using_rese/. Accessed August 15, 2020.
  • Wong S, Wilczynski N, Haynes R, Ramkissoonsingh RHT. Developing optimal search strategies for detecting sound clinical prediction studies in MEDLINE. AMIA Annu Symp Proc. 2003;728–732.
  • Strauss E, Sherman E, Spreen O. A Compendium of Neuropsychological Tests. 3rd ed. Oxford, England, UK: Oxford: University Press; 2006.
  • Lezak M, Howieson D, Bigler E, Tranel D. Neuropsychological Assessment. 5 revised ed. Oxford, England, UK: Oxford University Press Inc; 2012.
  • Mokkink L, Terwee C, Patrick D, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010;19(4):539–549. doi:10.1007/s11136-010-9606-8
  • Terwee C, Bot S, de Boer M, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34–42. doi:10.1016/j.jclinepi.2006.03.012
  • vanTulder M, Furland A, Bombardier C, Bouter L. Editorial board of the Cochrane back review group. Updated method guidelines for systematic reviews in the cochrane collaboration back review group. Spine. 2003;28:1290–1299. doi:10.1097/01.BRS.0000065484.95996.AF
  • World medical association. World medical association declaration of Helsinki - Ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194. doi:10.1001/jama.2013.281053
  • Floris G, Borghero G, Chiò A, et al. Cognitive screening in patients with amyotrophic lateral sclerosis in early stages. Amyotroph Lateral Scler. 2012;13:95–101. doi:10.3109/17482968.2011.605453
  • Abrahams S, Leigh P, Harvey A, Vythelingum G, Grise D, Goldstein L. Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia. 2000;38(6):734–747. doi:10.1016/S0028-3932(99)00146-3
  • Ji Y, Wei L, Chui D, Wang K, Fan D. Prospective memory tasks: a more sensitive method for screening cognitive impairment in ALS? BMC Neurol. 2012;12:142. doi:10.1186/1471-2377-12-142
  • Staios M, Fisher F, Lindell A, Ong B, Howe J, Reardon K. Exploring sarcasm detection in amyotrophic lateral sclerosis using ecologically valid measures. Front Hum Neurosci. 2013;7:178. doi:10.3389/fnhum.2013.00178
  • Papps B, Abrahams S, Wicks P, Leigh P, Goldstein L. Changes in memory for emotional material in amyotrophic lateral sclerosis (ALS). Neuropsychologia. 2005;43(8):1107–1114. doi:10.1016/j.neuropsychologia.2004.11.027
  • Burke T, Pinto-Grau M, Lonergan K, et al. Measurement of social cognition in amyotrophic lateral sclerosis: a population based study. PLoS One. 2016;11:8. doi:10.1371/journal.pone.0160850
  • Chenji S, Mah D, Johnston W, Camicioli R, Fisher N, Kalra S. Utility of the Addenbrooke’s cognitive examination in amyotrophic lateral sclerosis. Can J Neurol Sci. 2018;45(5):527–532. doi:10.1017/cjn.2018.68
  • Hsieh S, Caga J, Leslie F, et al. Cognitive and behavioral symptoms in ALSFTD: detection, differentiation, and progression. J Geriatr Psychiatry Neurol. 2016;29(1):3–10. doi:10.1177/0891988715598232
  • Masuda M, Watababe H, Tanaka Y, et al. Age-related impairment in Addenbrooke’s cognitive examination revised scores in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19(78):578–584. doi:10.1080/21678421.2018.1510009
  • Wei Q, Chen X, Zheng Z, et al. Screening for cognitive impairment in a Chinese ALS population. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(12):40–45. doi:10.3109/21678421.2014.966311
  • Kourtesis P, Christidi F, Margioti E, et al. The Edinburgh cognitive and behavioral amyotrophic lateral sclerosis screen (ECAS): sensitivity in differentiating between ALS and Alzheimer’s disease in a Greek population. Amyotroph Lateral Scler Frontotemporal Degener. 2019;30:1–8.
  • Xu Z, Alruwaili A, Henderson R, McCombe P. Screening for cognitive and behavioural impairment in amyotrophic lateral sclerosis: frequency of abnormality and effect on survival. J Neurol Sci. 2017;376:16–23. doi:10.1016/j.jns.2017.02.061
  • Hu W, Shelnutt M, Wilson A, et al. Behavior matters-cognitive predictors of survival in amyotrophic lateral sclerosis. PLoS One. 2013;8:2.
  • Murphy J, Factor-Litvak P, Goetz R, et al. Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort. Neurology. 2016;86(9):813–820. doi:10.1212/WNL.0000000000002305
  • Woolley SC, York MK, Moore DH, et al. Detecting frontotemporal dysfunction in ALS: utility of the ALS cognitive behavioral screen (ALS-CBS). Amyotroph Lateral Scler. 2010;11(3):303–311. doi:10.3109/17482961003727954
  • Branco L, De-Rezende T, Casseb R, Balthazar M, Woolley S, Franca M. Transcultural validation of the ALS-CBS cognitive section for the Brazilian population. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(12):60–67. doi:10.1080/21678421.2016.1211147
  • Tremolizzo L, Lizio A, Santangelo G, et al. ALS cognitive behavioral screen (ALS-CBS): normative values for the Italian population and clinical usability. Neurol Sci. 2019.
  • Turon-Sans J, Gascon-Bayarri J, Reñé R, et al. Cognitive impairment in ALS patients and validation of the Spanish version of the ALS-CBS test. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(34):221–227. doi:10.3109/21678421.2015.1125500
  • Burkhardt C, Neuwirth C, Weber M. Longitudinal assessment of the Edinburgh cognitive and behavioural amyotrophic lateral sclerosis screen (ECAS): lack of practice effect in ALS patients? Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(34):202–209. doi:10.1080/21678421.2017.1283418
  • Niven E, Newton J, Foley J, et al. Validation of the Edinburgh cognitive and behavioural amyotrophic lateral sclerosis screen (ECAS): A cognitive tool for motor disorders. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(34):172–179. doi:10.3109/21678421.2015.1030430
  • Pinto-Grau M, Burke T, Lonergan K, et al. Screening for cognitive dysfunction in ALS: validation of the Edinburgh cognitive and behavioural ALS screen (ECAS) using age and education adjusted normative data. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(12):99–106. doi:10.1080/21678421.2016.1249887
  • Lule D, Hörner K, Vazquez C, et al. Screening for cognitive function in complete immobility using brain-machine interfaces: A proof of principle study. Front Neurosci. 2018;12:517. doi:10.3389/fnins.2018.00517
  • Ye S, Li C, Liu X, Fan D. The Edinburgh cognitive and behavioural ALS screen in a Chinese amyotrophic lateral sclerosis population. PlosOne. 2016;11:5.
  • Lulé D, Burkhardt C, Abdulla S, et al. The Edinburgh cognitive and behavioural amyotrophic lateral sclerosis screen: a cross-sectional comparison of established screening tools in a German-Swiss population. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(12):16–23. doi:10.3109/21678421.2014.959451
  • Keller J, Krimly A, Bauer L, et al. A first approach to a neuropsychological screening tool using eye-tracking for bedside cognitive testing based on the Edinburgh cognitive and behavioural ALS screen. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(56):443–450. doi:10.1080/21678421.2017.1313869
  • Poletti B, Solca F, Carelli L, et al. The validation of the Italian Edinburgh cognitive and behavioural ALS screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(78):489–498. doi:10.1080/21678421.2016.1183679
  • Poletti B, Solca F, Carelli L, et al. Cognitive-behavioral longitudinal assessment in ALS: the Italian Edinburgh cognitive and behavioral ALS screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:387–395. doi:10.1080/21678421.2018.1473443
  • Mora J, Salas T, Fernández M, Rodriguez-Castillo V, Chaverri D, Rodriguez-Santos F. Spanish adaptation of the Edinburgh cognitive and behavioral amyotrophic lateral sclerosis screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2018;19(12):74–79. doi:10.1080/21678421.2017.1406952
  • Bezdíček O, Marková L, Soósová N, Forgáč M. Czech version of the Edinburgh cognitive and behavioral amyotrophic lateral sclerosis screen – a pilot study. Cesk Slov Neurol N. 2018;81(2):208–212. doi:10.14735/amcsnn2018208
  • Ahn S, Kim S, Kim J, et al. Frontal assessment battery to evaluate frontal lobe dysfunction in ALS patients. Can J Neurol Sci. 2011;38(2):242–246. doi:10.1017/S0317167100011409
  • Ohta Y, Sato K, Takemoto M, et al. Behavioral and affective features of amyotrophic lateral sclerosis patients. J Neurol Sci. 2017;381:119–125. doi:10.1016/j.jns.2017.08.024
  • Oskarsson B, Quan D, Rollins Y, Neville H, Ringel S, Arciniegas D. Using the Frontal assessment battery to identify executive function impairments in amyotrophic lateral sclerosis: A preliminary experience. Amyotroph Lateral Scler Frontotemporal Degener. 2010;11(12):244–247. doi:10.3109/17482960903059588
  • Barulli M, Fontana A, Panza F, et al. Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study. BMJ Open. 2015;5:9. doi:10.1136/bmjopen-2014-007069
  • Osborne R, Sekhon R, Johnston W, Kalra S. Screening for frontal lobe and general cognitive impairment in patients with amyotrophic lateral sclerosis. J Neurol Sci. 2014;336(12):191–196. doi:10.1016/j.jns.2013.10.038
  • Flaherty-Craig C, Brothers A, Yang C, Svoboda R, Simmons Z. Declines in problem solving and anosognosia in amyotrophic lateral sclerosis: application of Guilford’s structure of intellect theory. Cog Behav Neurol. 2011;24(2):26–34. doi:10.1097/WNN.0b013e3182138454
  • Christodoulou G, Gennings C, Hupf J, et al. Telephone based cognitive-behavioral screening for frontotemporal changes in patients with amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(78):482–488. doi:10.3109/21678421.2016.1173703
  • Murphy J, Ahmed F, Lomen-Hoerth C. The UCSF screening exam effectively screens cognitive and behavioral impairment in patients with ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(12):24–30. doi:10.3109/21678421.2014.960873
  • Gillingham S, Yunusova Y, Ganda A, et al. Assessing cognitive functioning in ALS: A focus on frontal lobe processes. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(34):182–192. doi:10.1080/21678421.2016.1248977
  • Gordon PH, Wang Y, Doorish C, et al. A screening assessment of cognitive impairment in patients with ALS. Amyotrophic Lateral Sclerosis. 2007;8:362–365. doi:10.1080/17482960701500817
  • Lillo P, Savage S, Mioshi E, Kiernan M, Hodges J. Amyotrophic lateral sclerosis and frontotemporal dementia: A behavioural and cognitive continuum. Amyotroph Lateral Scler. 2012;13(1):102–109. doi:10.3109/17482968.2011.639376
  • Nidos A, Kasselimis D, Simos P, et al. Frontotemporal dysfunction in amyotrophic lateral sclerosis: A discriminant function analysis. Neurodegener Dis. 2016;16(34):140–146. doi:10.1159/000381186
  • Tsermentseli S, Leigh P, Taylor L, Radunovic A, Catani M, Goldstein L. Syntactic processing as a marker for cognitive impairment in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2015;17(12):69–76. doi:10.3109/21678421.2015.1071397
  • Heidler-Gary J, Hillis A. Distinctions between the dementia in amyotrophic lateral sclerosis with frontotemporal dementia and the dementia of Alzheimer’s disease. Amyotroph Lateral Scler. 2007;8(5):276–282. doi:10.1080/17482960701381911
  • Baylor C, Yorkston K, Eadie T, Kim J, Chung H, Amtmann D. The Communicative participation item bank (CPIB): item bank calibration and development of a disorder-generic short form. J Speech Lang Hear Res. 2013;56(4):1190–1208. doi:10.1044/1092-4388(2012/12-0140)
  • Gallassi R, Montagna P, Ciardulli C, Lorusso S, Mussuto V, Stracciari A. Cognitive impairment in motor neuron disease. Acta Neurol Scand. 1985;71(6):480–484. doi:10.1111/j.1600-0404.1985.tb03231.x
  • Altman D. Practical Statistics for Medical Research. London: Chapman and Hall; 1991.
  • Simon N, Goldstein L. Screening for cognitive and behavioral change in amyotrophic lateral sclerosis/motor neuron disease: a systematic review of validated screening methods. Amyotroph Lateral Scler Frontotemporal Degener. 2018;20:1–11. doi:10.1080/21678421.2018.1530264
  • Crockford CJ, Kleynhans M, Wilton E, et al. ECAS A-B-C: alternate forms of the edinburgh cognitive and behavioural ALS screen. Amyotroph Lat Scl Fr. 2018;19(12):57–64.
  • Baron-Cohen S, Wheelwright S, Hill J, Raste Y, The IP. Reading in the mind in the eyes” test revised version: a study with normal adults, and adults with asperger syndrome or high-functioning autism. J Child Psychol Psychiatry. 2001;42:241–251. doi:10.1111/1469-7610.00715
  • Taule T, AS. M, Renså M, Aßmus J, Tysnes O, Rekand T. Edinburgh cognitive and behavioural amyotrophic lateral sclerosis screen (ECAS) in Norway: protocol for validation and a prospective cohort study. Contemp Clin Trials Commun. 2019;14.